Thirteen patients with sickle cell disease reporting priapism recurrences at least twice weekly were randomized to receive sildenafil @ mg or placebo daily , unassociated with sleep or sexual activity , for @ weeks , followed by open-label use of this sildenafil regimen for an additional @ weeks .